Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
30.03.2022 - – Company strengthens strategic focus on rare disease and immuno-oncology assets and details expected upcoming clinical milestones – – SerpinPC registration studies planned to begin in 2H 2022 following recent FDA meeting; initial focus on ...